Bain Capital Public Equity Management II’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Bain Capital Public Equity Management II's NVS Position: Q2 2020 in Review
Bain Capital Public Equity Management II sold out of Novartis (NVS) in Q2 2020, closing a stake of 440,233 shares — an estimated $36.3M sold.
Bain Capital Public Equity Management II first reported a position in NVS in Q2 2019 and held it in 4 quarters. The position peaked at $89.9M in Q2 2019. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.
- Bain Capital Public Equity Management II reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
- Bain Capital Public Equity Management II sold 440,233 Novartis shares in Q2 2020, an estimated $36.3M.
- Bain Capital Public Equity Management II first reported a position in Novartis in Q2 2019 and held it in 4 quarters.
- Bain Capital Public Equity Management II's Novartis position peaked at $89.9M in Q2 2019.
- 1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.
Based on Bain Capital Public Equity Management II's 13F filing for Q2 2020, filed 14 Aug 2020.